Pharmaceutical company Merck is nearing a roughly $6 billion all-cash deal to acquire biotech firm Terns Pharma, the Financial Times reported on Tuesday, citing people familiar with the matter. The potential...
Pharmaceutical
Gilead Sciences buys autoimmune biotech Ouro Medicines for $2.2bn
Gilead Sciences is buying autoimmune disease biotech Ouro Medicines for nearly $2.2bn as the drugmaker kick-starts a dealmaking spree emboldened by its near-record share price. The California-based company will pay...
Encube Ethicals stake sale on hold, IPO likely by 2027
Encube Ethicals has paused plans to sell a majority stake due to a valuation mismatch, said people familiar with the matter. Instead, the company is exploring the possibility of an initial public offering (IPO) by 2027...
Strides Pharma to acquire Sandoz branded generics portfolio to expand Africa business
Strides Pharma International AG, a step‑down subsidiary of Bengaluru-based Strides Pharma Science, has entered into definitive agreements with Sandoz AG, Switzerland and its group entities for the acquisition and...
GSK to buy 35Pharma for $950 million in CEO Miel’s second major deal
GSK has agreed to pay $950 million in cash for Canadian biotech 35Pharma, it said on Wednesday, marking the second major deal new CEO Luke Miels has struck to accelerate development of new medicines at the British...
Novartis AG to sell entire 70.68% stake for ₹1,445.89 crore in India unit; stock jumps 18%
Novartis India share price surged 18% in intra-day trade on Friday, February 20, after promoter Novartis AG agreed to sell its entire stake in the company, triggering a mandatory open offer and a complete change in...
Alkem Labs unit to buy up to 55% of Occlutech for $118 million
Alkem Laboratories’ medical devices unit will buy up to a 55% stake in Switzerland’s Occlutech Holding for 99.4 million euros ($118 million), the Indian pharma company said on Friday, marking its entry into...
Alkem Labs unit to buy up to 55% of Occlutech for $118 million
Alkem Laboratories’ medical devices unit will buy up to a 55% stake in Switzerland’s Occlutech Holding for 99.4 million euros ($118 million), the Indian pharma company said on Friday, marking its entry into...
USV Pharma leads race to buy 85% stake in Wellbeing Nutrition at Rs 1,600 crore valuation
USV Pharma has emerged as the frontrunner for acquiring an 85% stake in Wellbeing Nutrition, valuing the direct-to-consumer supplements brand at about Rs 1,600 crore, said people familiar with the discussions. The...
Warburg-Mubadala team up, emerge as frontrunner for Encube
A consortium of Warburg Pincus and Abu Dhabi sovereign wealth fund Mubadala has emerged as the frontrunner to acquire a majority stake of up to 74% in Mumbai-based Encube Ethicals, a generics and pharmaceutical contract...
Aurobindo Pharma board considers merger of subsidiaries
Approves the filing of scheme of merger of Auro Vaccines with Curateq Biologics The board of Aurobindo Pharma at its meeting held on 09 February 2026 has approved a proposal to file a scheme of amalgamation for merger...
NATCO Pharma Asia acquires 49% stake in PT NATCO Lotus Farma
NATCO Pharma Asia, a wholly-owned subsidiary (WOS) of Natco Pharma (NATCO) incorporated in Singapore, has acquired 49% of the shareholding in PT NATCO Lotus Farma from PT Lotus Farma Indonesia. NATCO already owns 51% of...
